Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Arsenic | 28 | 2026 | 65 | 7.800 |
Why?
|
| Environmental Exposure | 19 | 2026 | 578 | 4.350 |
Why?
|
| Water Pollutants, Chemical | 12 | 2026 | 227 | 3.670 |
Why?
|
| Uranium | 8 | 2025 | 27 | 2.370 |
Why?
|
| Oryza | 4 | 2026 | 32 | 1.620 |
Why?
|
| Drinking Water | 8 | 2026 | 89 | 1.540 |
Why?
|
| Lung Diseases | 4 | 2022 | 780 | 1.510 |
Why?
|
| Water Supply | 5 | 2025 | 89 | 1.490 |
Why?
|
| Atherosclerosis | 7 | 2024 | 409 | 1.460 |
Why?
|
| Cadmium | 7 | 2025 | 68 | 1.370 |
Why?
|
| Metals | 5 | 2026 | 136 | 1.330 |
Why?
|
| Selenium | 3 | 2024 | 50 | 1.140 |
Why?
|
| Nutrition Surveys | 5 | 2024 | 279 | 1.050 |
Why?
|
| Mercury | 2 | 2023 | 41 | 0.950 |
Why?
|
| Trihalomethanes | 1 | 2025 | 6 | 0.910 |
Why?
|
| Dietary Exposure | 2 | 2026 | 8 | 0.900 |
Why?
|
| Extracellular Vesicles | 2 | 2025 | 171 | 0.880 |
Why?
|
| Forced Expiratory Volume | 6 | 2026 | 450 | 0.860 |
Why?
|
| California | 7 | 2026 | 471 | 0.860 |
Why?
|
| Volatile Organic Compounds | 1 | 2024 | 46 | 0.840 |
Why?
|
| Indians, North American | 3 | 2024 | 597 | 0.790 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 3 | 2026 | 919 | 0.770 |
Why?
|
| Cardiovascular Diseases | 6 | 2026 | 2187 | 0.710 |
Why?
|
| Lung Diseases, Obstructive | 2 | 2020 | 43 | 0.700 |
Why?
|
| Renal Insufficiency, Chronic | 2 | 2025 | 668 | 0.690 |
Why?
|
| Coronary Artery Disease | 2 | 2026 | 749 | 0.680 |
Why?
|
| MicroRNAs | 2 | 2025 | 686 | 0.680 |
Why?
|
| Blood Pressure | 3 | 2024 | 1779 | 0.640 |
Why?
|
| Edible Grain | 1 | 2020 | 47 | 0.640 |
Why?
|
| School Teachers | 3 | 2024 | 29 | 0.630 |
Why?
|
| Longitudinal Studies | 8 | 2026 | 2953 | 0.590 |
Why?
|
| Middle Aged | 26 | 2026 | 36215 | 0.570 |
Why?
|
| Hypertension | 2 | 2024 | 1273 | 0.550 |
Why?
|
| Female | 39 | 2026 | 78844 | 0.530 |
Why?
|
| Vital Capacity | 4 | 2026 | 292 | 0.530 |
Why?
|
| Prospective Studies | 15 | 2026 | 8057 | 0.500 |
Why?
|
| Cannabis | 1 | 2023 | 509 | 0.480 |
Why?
|
| Humans | 50 | 2026 | 145474 | 0.460 |
Why?
|
| Zinc | 5 | 2026 | 306 | 0.450 |
Why?
|
| Adult | 23 | 2026 | 40777 | 0.450 |
Why?
|
| Neoplasms | 2 | 2021 | 2906 | 0.440 |
Why?
|
| Aged | 18 | 2026 | 26153 | 0.440 |
Why?
|
| Water Purification | 2 | 2016 | 156 | 0.430 |
Why?
|
| Trace Elements | 2 | 2026 | 52 | 0.430 |
Why?
|
| Bangladesh | 6 | 2026 | 63 | 0.410 |
Why?
|
| Spirometry | 4 | 2025 | 233 | 0.380 |
Why?
|
| Male | 29 | 2026 | 72842 | 0.380 |
Why?
|
| Lung Diseases, Interstitial | 1 | 2019 | 664 | 0.370 |
Why?
|
| Diabetes Mellitus | 1 | 2021 | 1097 | 0.370 |
Why?
|
| Risk Factors | 10 | 2025 | 10885 | 0.360 |
Why?
|
| United States | 14 | 2026 | 16098 | 0.360 |
Why?
|
| Cohort Studies | 6 | 2026 | 6013 | 0.350 |
Why?
|
| Respiratory Tract Infections | 1 | 2016 | 396 | 0.340 |
Why?
|
| Environmental Monitoring | 5 | 2024 | 346 | 0.330 |
Why?
|
| Biomarkers | 7 | 2025 | 4295 | 0.320 |
Why?
|
| Public Health | 3 | 2024 | 572 | 0.320 |
Why?
|
| Cobalt | 3 | 2024 | 50 | 0.310 |
Why?
|
| DNA Methylation | 3 | 2024 | 674 | 0.310 |
Why?
|
| Aged, 80 and over | 7 | 2026 | 8333 | 0.300 |
Why?
|
| Respiration Disorders | 2 | 2020 | 78 | 0.290 |
Why?
|
| Manganese | 3 | 2024 | 55 | 0.290 |
Why?
|
| Lead | 3 | 2024 | 71 | 0.280 |
Why?
|
| Tungsten | 2 | 2024 | 30 | 0.270 |
Why?
|
| Copper | 2 | 2024 | 119 | 0.250 |
Why?
|
| Lung | 4 | 2022 | 4106 | 0.240 |
Why?
|
| Food Contamination | 1 | 2026 | 33 | 0.240 |
Why?
|
| Nickel | 2 | 2024 | 62 | 0.240 |
Why?
|
| Cooking | 1 | 2026 | 57 | 0.230 |
Why?
|
| Respiratory Function Tests | 2 | 2019 | 544 | 0.230 |
Why?
|
| Halogenation | 1 | 2025 | 22 | 0.230 |
Why?
|
| Smoking | 4 | 2025 | 1472 | 0.220 |
Why?
|
| Butadienes | 1 | 2024 | 33 | 0.220 |
Why?
|
| Trees | 1 | 2024 | 59 | 0.210 |
Why?
|
| Arsenicals | 2 | 2021 | 28 | 0.200 |
Why?
|
| Cities | 1 | 2024 | 138 | 0.200 |
Why?
|
| Cigarette Smoking | 1 | 2025 | 102 | 0.200 |
Why?
|
| Tobacco Products | 1 | 2024 | 84 | 0.200 |
Why?
|
| Barium | 1 | 2023 | 27 | 0.200 |
Why?
|
| Tin | 1 | 2023 | 9 | 0.200 |
Why?
|
| Vascular Calcification | 1 | 2024 | 110 | 0.190 |
Why?
|
| Bayes Theorem | 2 | 2021 | 420 | 0.180 |
Why?
|
| Diet | 2 | 2020 | 1277 | 0.170 |
Why?
|
| Repressor Proteins | 1 | 2024 | 429 | 0.170 |
Why?
|
| Incidence | 3 | 2025 | 2923 | 0.160 |
Why?
|
| Residence Characteristics | 1 | 2024 | 375 | 0.160 |
Why?
|
| Prevalence | 2 | 2025 | 2865 | 0.160 |
Why?
|
| Environmental Pollutants | 1 | 2021 | 139 | 0.150 |
Why?
|
| Ovarian Neoplasms | 1 | 2026 | 595 | 0.150 |
Why?
|
| Pulmonary Surfactant-Associated Protein A | 1 | 2019 | 30 | 0.150 |
Why?
|
| Vaping | 1 | 2020 | 74 | 0.150 |
Why?
|
| Non-alcoholic Fatty Liver Disease | 1 | 2022 | 265 | 0.150 |
Why?
|
| Electronic Nicotine Delivery Systems | 1 | 2020 | 110 | 0.140 |
Why?
|
| Cross-Sectional Studies | 5 | 2022 | 5904 | 0.140 |
Why?
|
| Disease Progression | 2 | 2024 | 2864 | 0.140 |
Why?
|
| Coronary Disease | 1 | 2021 | 381 | 0.140 |
Why?
|
| Sulfones | 1 | 2019 | 127 | 0.140 |
Why?
|
| Eating | 1 | 2020 | 387 | 0.130 |
Why?
|
| Metabolome | 1 | 2021 | 388 | 0.130 |
Why?
|
| Young Adult | 5 | 2026 | 14218 | 0.130 |
Why?
|
| Maternal Exposure | 1 | 2018 | 189 | 0.120 |
Why?
|
| Tuberculosis | 1 | 2020 | 283 | 0.120 |
Why?
|
| Memory, Short-Term | 1 | 2018 | 268 | 0.110 |
Why?
|
| Carbon Monoxide | 1 | 2015 | 82 | 0.110 |
Why?
|
| Pyrimidines | 1 | 2019 | 530 | 0.110 |
Why?
|
| Creatine | 1 | 2015 | 63 | 0.110 |
Why?
|
| Inhalation Exposure | 1 | 2015 | 103 | 0.110 |
Why?
|
| Nitrates | 2 | 2026 | 93 | 0.110 |
Why?
|
| Family Characteristics | 1 | 2016 | 195 | 0.110 |
Why?
|
| Epidemiologic Studies | 2 | 2024 | 68 | 0.100 |
Why?
|
| Age Factors | 2 | 2025 | 3342 | 0.100 |
Why?
|
| Folic Acid | 1 | 2015 | 198 | 0.100 |
Why?
|
| Air Pollution, Indoor | 1 | 2015 | 171 | 0.100 |
Why?
|
| Surveys and Questionnaires | 2 | 2024 | 6066 | 0.100 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2019 | 981 | 0.090 |
Why?
|
| Heart Failure | 1 | 2025 | 2326 | 0.090 |
Why?
|
| Pregnancy | 1 | 2023 | 7202 | 0.080 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2019 | 1189 | 0.080 |
Why?
|
| Sex Factors | 1 | 2016 | 2105 | 0.080 |
Why?
|
| Cognition | 1 | 2018 | 1266 | 0.080 |
Why?
|
| Water | 2 | 2023 | 445 | 0.070 |
Why?
|
| National Heart, Lung, and Blood Institute (U.S.) | 1 | 2026 | 103 | 0.060 |
Why?
|
| Mortality, Premature | 1 | 2025 | 15 | 0.060 |
Why?
|
| Lung Neoplasms | 1 | 2019 | 2664 | 0.060 |
Why?
|
| Spain | 1 | 2025 | 50 | 0.060 |
Why?
|
| Hospitalization | 2 | 2026 | 2460 | 0.060 |
Why?
|
| Ethiopia | 1 | 2024 | 44 | 0.050 |
Why?
|
| New York City | 1 | 2024 | 84 | 0.050 |
Why?
|
| Kenya | 1 | 2024 | 129 | 0.050 |
Why?
|
| Forests | 1 | 2024 | 48 | 0.050 |
Why?
|
| Molybdenum | 1 | 2024 | 6 | 0.050 |
Why?
|
| Adolescent | 4 | 2025 | 22529 | 0.050 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2024 | 592 | 0.050 |
Why?
|
| Apolipoproteins E | 1 | 2022 | 93 | 0.040 |
Why?
|
| Stroke Volume | 1 | 2025 | 654 | 0.040 |
Why?
|
| Environmental Pollution | 1 | 2021 | 20 | 0.040 |
Why?
|
| Proportional Hazards Models | 1 | 2025 | 1327 | 0.040 |
Why?
|
| Cooperative Behavior | 1 | 2024 | 462 | 0.040 |
Why?
|
| Cacodylic Acid | 1 | 2021 | 2 | 0.040 |
Why?
|
| Research | 1 | 2024 | 430 | 0.040 |
Why?
|
| Mass Spectrometry | 1 | 2024 | 730 | 0.040 |
Why?
|
| Observational Studies as Topic | 1 | 2020 | 133 | 0.040 |
Why?
|
| Liver Cirrhosis | 1 | 2022 | 287 | 0.040 |
Why?
|
| Colony Count, Microbial | 1 | 1999 | 89 | 0.040 |
Why?
|
| Rifampin | 1 | 1999 | 79 | 0.030 |
Why?
|
| Wechsler Scales | 1 | 2018 | 61 | 0.030 |
Why?
|
| United States Environmental Protection Agency | 1 | 2017 | 28 | 0.030 |
Why?
|
| Microbial Sensitivity Tests | 1 | 1999 | 364 | 0.030 |
Why?
|
| Antitubercular Agents | 1 | 1999 | 208 | 0.030 |
Why?
|
| Prognosis | 1 | 2025 | 4316 | 0.030 |
Why?
|
| Administration, Oral | 1 | 2019 | 866 | 0.030 |
Why?
|
| Breath Tests | 1 | 2015 | 77 | 0.030 |
Why?
|
| Mycobacterium tuberculosis | 1 | 1999 | 318 | 0.030 |
Why?
|
| Neoplasm Staging | 1 | 2019 | 1471 | 0.030 |
Why?
|
| Methylation | 1 | 2015 | 242 | 0.030 |
Why?
|
| Logistic Models | 1 | 2020 | 2134 | 0.030 |
Why?
|
| Time Factors | 1 | 2025 | 7123 | 0.030 |
Why?
|
| Creatinine | 1 | 2015 | 515 | 0.020 |
Why?
|
| Mothers | 1 | 2018 | 765 | 0.020 |
Why?
|
| Feasibility Studies | 1 | 2015 | 1111 | 0.020 |
Why?
|
| Dietary Supplements | 1 | 2015 | 583 | 0.020 |
Why?
|
| Mice | 1 | 2022 | 18329 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2019 | 11853 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2019 | 11772 | 0.010 |
Why?
|
| Animals | 1 | 2022 | 38030 | 0.010 |
Why?
|
| Child | 1 | 2019 | 22707 | 0.010 |
Why?
|
| Drug Resistance, Microbial | 1 | 1999 | 64 | 0.010 |
Why?
|
| Quality Control | 1 | 1999 | 161 | 0.010 |
Why?
|
| Culture Media | 1 | 1999 | 161 | 0.010 |
Why?
|
| Mutation | 1 | 1999 | 4075 | 0.000 |
Why?
|